Original Article

You have full text access to this OnlineOpen article

Increased activity of guanosine 3′-5′-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites

Paolo Angeli Ph.D.^1,*,
Wladimiro Jiménez²,
Rosalia Veggian¹,
Silvano Fasolato¹,
Roberta Volpin¹,
Harald S. MacHenzie⁴,
Raffaella Craighero¹,
Virna Dalla Libera¹,
Antonietta Sticca¹,
Vicente Arroyo³,
Angelo Gatta¹

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510310207

Issue

Hepatology

Volume 31, Issue 2, pages 304–310, February 2000

Additional Information

How to Cite

Angeli, P., Jiménez, W., Veggian, R., Fasolato, S., Volpin, R., MacHenzie, H. S., Craighero, R., Dalla Libera, V., Sticca, A., Arroyo, V. and Gatta, A. (2000), Increased activity of guanosine 3′-5′-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites. Hepatology, 31: 304–310. doi: 10.1002/hep.510310207

Author Information

¹
Department of Clinical and Experimental Medicine, University of Padua, Italy
²
Hormonal Laboratory University of Barcelona, Spain
³
Liver Unit, Hospital Clinic Universitari, Institut d'Investigacions Biomèdiques August Pí Sunyer (IDIBAPS), University of Barcelona, Spain
⁴
Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA

Email: Angelo Gatta (pangeli@ux1.unipd.it)

^*Department of Clinical and Experimental Medicine, Via Giustiniani 2, Padova 35100, Italy. fax: ++39-(049)-8754179

Publication History

Issue published online: 30 DEC 2003
Article first published online: 30 DEC 2003
Manuscript Accepted: 10 NOV 1999
Manuscript Received: 21 MAY 1999

Funded by

Regione Veneto, Italy. Grant Number: 636/01/96
Plan Nacional de I+D, Comisión Interministerial de Ciencia y Tecnología. Grant Number: SAF99-0016

ARTICLE TOOLS

Abstract
References
Cited By

Get PDF (136K)

References

1
Jamison RL, Canaan-Kühl S, Pratt R. The natriuretic peptides and their receptors. Am J Kidney Dis 1992; 20:519–530.MEDLINE
2
Flynn TG, de Bold MI, de Bold AJ. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 1983; 117:859–865.MEDLINE
3
Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ongawa Y, Shirakami G, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 1991; 87:1402–1412.MEDLINE
4
Sudoth T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP); a new member of the natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990; 168:863–870.MEDLINE
5
Schulz-Knappe P, Forssmann K, Herbest F, Hick D, Pipkorn R, Forssmann WG. Isolation and structural analysis of “urodilatin,” a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Whochenschr 1988; 66:752–759.
6
Gerbes AL, Arendt RM, Ritter D, Jungst D, Zahringer J, Paumgartner G. Plasma atrial natriuretic factor in patients with cirrhosis. N Engl J Med 1985; 313:1609–1610.MEDLINE
7
Ginès P, Jiménez W, Arroyo V, Navasa M, Lopez C, Tito L, Serra A, et al. Atrial natriuretic factor in cirrhosis with ascites; plasma levels, cardiac release and splanchnic extraction. Hepatology 1988; 8:636–642.MEDLINE
Direct Link:
8
La Villa G, Romanelli RG, Casini Raggi V, Tosti Guerra C, De Feo ML, Marra F, Laffi G, et al. Plasma levels of brain natriuretic peptide in patients with cirrhosis. Hepatology 1992; 16:156–161.MEDLINE
Direct Link:
9
Salo J, Jiménez W, Kuhn M, Ginès A, Ginès P, Fernandez-Esparrach G, Angeli P, et al. Urinary excretion of urodilatin in patients with cirrhosis. Hepatology 1996; 24:1428–1432.MEDLINE
Direct Link:
10
Angeli P, Caregaro L, Menon F, Sacerdoti D, De Toni R, Merkel C, Gatta A. Variability of atrial natriuretic peptide in ascitic cirrhotics: pathophysiological and clinical implications. Hepatology 1992; 16:1389–1394.MEDLINE
Direct Link:
11
Jiménez W, Gutkowska J, Ginés P, Arroyo V, Rivera F, Rodés J. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites. Hepatology 1991; 14:601–607.MEDLINE
- PubMed,
- Web of Science® Times Cited: 23
12
Angeli P, Jiménez W, Arroyo V, MacKenzie HS, Zhang PL, Claria J, et al. Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites. Hepatology 1994; 20:948–954.MEDLINE
Direct Link:
13
Salerno F, Badalamenti S, Incerti P, Capozza L, Mainardi L. Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis. Hepatology 1988; 8:21–26.MEDLINE
Direct Link:
14
Laffi G, Pinzani M, Meacci E, La Villa G, Renzi D, Baldi E, Cominelli F, et al. Renal haemodynamic and natriuretic effects of atrial natriuretic factor infusion in cirrhosis with ascites. Gastroenterology 1989; 96:167–177.MEDLINE
15
Ginès P, Tito L, Arroyo V, Llach J, Salmeron JM, Ginès A, Jiménez W, et al. Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure. Gastroenterology 1992; 102:280–286.MEDLINE
- PubMed,
- Web of Science® Times Cited: 34
16
La Villa G, Riccardi D, Lazzeri C, Casini Raggi V, Dello Sbarba A, Tosti Guerra C, Fronzaroli C, et al. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid odium retention. Hepatology 1995; 22:1745–1750.MEDLINE
Direct Link:
17
Komeichi H, Moreau R, Cailmail S, Gaudin C, Lebrec D. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with ascites. J Hepatol 1995; 22:319–325.MEDLINE
18
Suga SI, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, et al. Receptor selectivity of natriuretic peptide family atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992; 130:229–239.MEDLINE
19
Chang MS, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclase. Nature 1989; 341:68–72.MEDLINE
20
Valentin JP, Sechi LA, Qiu C, Schambelan M, Humphreys MH. Urodilatin binds to and activates renal receptors for atrial natriuretic peptide. Hypertension 1993; 21:432–438.MEDLINE
21
Ballermann BJ, Brenner BM. Biologically active atrial peptides. J Clin Invest 1985; 76:2041–2048.MEDLINE
22
Tobe SW, Blendis LM, Morali GA, Warner LC, Logan AG, Skorecki KL. Angiotensin II modulates atrial natriuretic factor-induced natriuresis in cirrhosis with ascites. Am J Kidney Dis 1993; 21:472–479.MEDLINE
23
Warner LC, Skorecki KL, Blendis LM, Epstein M. Atrial natriuretic factor and liver disease. Hepatology 1993; 17:500–513.MEDLINE
Direct Link:
24
Wong F, Blendis LM. Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor. Semin Liver Dis 1994; 14:59–70.MEDLINE
25
Epstein M. Atrial natriuretic factor in patients with liver disease. Am J Nephrol 1989; 40:277–279.
26
Dussaule JC, Grangé JD, Wolf JP, Lacompte JM, Gros C, Schwartz JC, Bodin F, et al. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and odium urinary excretion in cirrhotic patients with ascites. J Clin Endocrinol Metab 1991; 72:653–659.MEDLINE
27
Gerbes AL, Kollenda MC, Vollmar AM, Reichen J, Vakil N, Scarborough RM. Altered density of glomerular binding sites for atrial natriuretic factor in bile-duct ligated rats with ascites. Hepatology 1991; 13:562–566.MEDLINE
28
Beavo JA, Conti M, Heaslip RJ. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 1994; 46:399–405.MEDLINE
29
Beavo JA. Cyclic nucleotide phosphodiesterase: functional implications of multiple isoforms. Physiol Rev 1995; 75:725–748.MEDLINE
30
Wilkins MR, Settle SL, Stockmann PT, Needelman P. Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci U S A 1990; 87:6465–6469.MEDLINE
31
Supaporn T, Sandeberg SM, Borgeson DD, Heublein DM, Luchner A, Wei CM, Dousa P, et al. Blunted cGMP response to agonists and enhanced glomerular cyclic 3′,5′-nucleotide phosphodiesterase activities in experimental congestive heart failure. Kidney Int 1996; 50:1718–1725.MEDLINE
32
Valentin JO, Changbin QIU, Muldowney WP, Wei-Zong Y, Gardner DG, Humphreys MH. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome. J Clin Invest 1992; 90:1302–1312.MEDLINE
33
Lopéz-Novoa JM, Rengel MA, Hernando L. Dynamics of ascites formation in rats with experimental cirrhosis. Am J Physiol 1980; 238:F353–F357.MEDLINE
- PubMed,
- Web of Science® Times Cited: 82
34
Jiménez W, Martinez-Pardo A, Arroyo V, Bruix V, Rimola A, Gaya J, Rivera F, et al. Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis. Hepatology 1985; 5:245–250.MEDLINE
Direct Link:
35
Jiménez W, Martinez-Pardo A, Arroyo V, López C, Rimola A, Gaya J, Rivera F. Influencia del método de extracción sanguínea sobre los niveles plasmáticos de renina en ratas Wistar. Rev Clin Fisiol 1985; 41:299–304.
- PubMed,
- Web of Science® Times Cited: 7
36
Thompson WJ, Appleman MM. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemestry 1971; 10:311–316.
37
Ni X, Cheng J, Cao L, Gardner DG, Humphreys MH. Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation. J Am Soc Nephrol 1996; 72:2110–2118.
38
Dundore RL, Clas DM, Wheeler LT, Habeeb PG, Bode DC, Buchholz RA, Sliver PJ, et al. Zaprinast increases cyclic GMP levels in plasma and aortic tissue of rats. Eur J Pharmacol 1993; 249:293–297.MEDLINE
39
Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990; 70:665–699.MEDLINE
40
Morishita Y, Sano T, Ikase H, Yamada K, Ingami T, Matsuda Y. HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist, blocks ANP-induced renal responses through a specific interaction with guanylyl cyclase-linked receptors. Eur J Pharmacol 1992; 225:203–207.MEDLINE
41
Zhang PL, Mackenzie HS, Troy JL, Brenner BM. Effects of an atrial natriuretic peptide receptor antagonist, on glomerular hyperfiltration in diabetic rats. J Am Soc Nephrol 1994; 4:1564–1570.MEDLINE
42
Bosch-Marcé M, Morales-Ruiz M, Jimenéz W, Bordas N, Solé M, Ros J, Deulofeu R, et al. Increased renal expression of nitric oxide synthase type II in cirrhotic rats with ascites. Hepatology 1998; 27:1191–1199.MEDLINE
Direct Link:

Get PDF (136K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Increased activity of guanosine 3′-5′-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites

Hepatology

How to Cite

Author Information

Publication History

Funded by

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Increased activity of guanosine 3′-5′-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites

Hepatology

How to Cite

Author Information

Publication History

Funded by

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this